Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  1,040 results for ""COVID-19""

Your Filters

Subject : mutation Filter by : Subject
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Sporadic Occurrence of Ensitrelvir-Resistant SARS-CoV-2, Japan.

Subjects: SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/genetics ; COVID-19*/COVID-19*/COVID-19*/epidemiology ; COVID-19*/COVID-19*/COVID-19*/virology

  • Source: Emerging infectious diseases [Emerg Infect Dis] 2024 Jun; Vol. 30 (6), pp. 1289-1291. Date of Electronic Publication: 2024 Apr 26.Publisher: National Center for Infectious Diseases, Centers for Disease Control and Prevention (CDC) Country of Publication: United States NLM ID: 9508155

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Evidence of SARS-CoV-2 convergent evolution in immunosuppressed patients treated with antiviral therapies.

  • Authors : Feng S; Department of Microbiology and Immunology, Stritch School of Medicine, Loyola University Chicago, Maywood, IL, 60153, USA.; Reid GE

Subjects: SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/genetics ; SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/immunology ; Immunocompromised Host* SARS-CoV-2 variants

  • Source: Virology journal [Virol J] 2024 May 07; Vol. 21 (1), pp. 105. Date of Electronic Publication: 2024 May 07.Publisher: BioMed Central Country of Publication: England NLM ID: 101231645 Publication Model: Electronic Cited Medium: Internet ISSN: 1743-422X

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Utilizing noncatalytic ACE2 protein mutant as a competitive inhibitor to treat SARS-CoV-2 infection.

  • Authors : Liu S; Avirmax Biopharma Inc., Hayward, CA, United States.; Chen H

Subjects: Angiotensin-Converting Enzyme 2*/Angiotensin-Converting Enzyme 2*/Angiotensin-Converting Enzyme 2*/genetics ; Angiotensin-Converting Enzyme 2*/Angiotensin-Converting Enzyme 2*/Angiotensin-Converting Enzyme 2*/metabolism ; SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/genetics

  • Source: Frontiers in immunology [Front Immunol] 2024 Apr 05; Vol. 15, pp. 1365803. Date of Electronic Publication: 2024 Apr 05 (Print Publication: 2024).Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

SARS-CoV-2 journey: from alpha variant to omicron and its sub-variants.

  • Authors : Hattab D; School of Pharmacy, The University of Jordan, Queen Rania Street, Amman, Jordan.; Amer MFA

Subjects: SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/genetics ; SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/immunology ; COVID-19*/COVID-19*/COVID-19*/virology SARS-CoV-2 variants

  • Source: Infection [Infection] 2024 Jun; Vol. 52 (3), pp. 767-786. Date of Electronic Publication: 2024 Mar 30.Publisher: Springer Heidelberg Country of Publication: Germany NLM ID: 0365307 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Dynamic diversity of SARS-CoV-2 genetic mutations in a lung transplantation patient with persistent COVID-19.

  • Authors : Igari H; Department of Infectious Diseases, Chiba University Hospital, Chiba, Chiba, Japan. .; Future Mucosal Vaccine Research and Development Center, Chiba University Hospital, Chiba, Chiba, Japan. .

Subjects: Alanine*/Alanine*/Alanine*/*analogs & derivatives; SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/genetics ; COVID-19*/COVID-19*/COVID-19*/virology SARS-CoV-2 variants

  • Source: Nature communications [Nat Commun] 2024 Apr 29; Vol. 15 (1), pp. 3604. Date of Electronic Publication: 2024 Apr 29.Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Spike Protein Genetic Evolution in Patients at High Risk of Severe Coronavirus Disease 2019 Treated by Monoclonal Antibodies.

  • Authors : Leducq V; Sorbonne Université, Inserm, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Assistance Publique-Hôpitaux de Paris, Hôpitaux Universitaires Pitié-Salpêtrière-Charles Foix, Laboratoire de virologie, Paris, France.; Zafilaza K

Subjects: Spike Glycoprotein, Coronavirus*/Spike Glycoprotein, Coronavirus*/Spike Glycoprotein, Coronavirus*/genetics ; Spike Glycoprotein, Coronavirus*/Spike Glycoprotein, Coronavirus*/Spike Glycoprotein, Coronavirus*/immunology ; SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/genetics

  • Source: The Journal of infectious diseases [J Infect Dis] 2024 May 15; Vol. 229 (5), pp. 1341-1351.Publisher: Oxford University Press Country of Publication: United States NLM ID: 0413675 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

COVID-19 Variants and Vaccine Development.

  • Authors : Zhao Z; School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, QLD 4072, Australia.; Bashiri S

Subjects: SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/immunology ; SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/genetics ; COVID-19 Vaccines*/COVID-19 Vaccines*/COVID-19 Vaccines*/immunology SARS-CoV-2 variants

  • Source: Viruses [Viruses] 2024 May 10; Vol. 16 (5). Date of Electronic Publication: 2024 May 10.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101509722 Publication Model: Electronic Cited Medium: Internet ISSN: 1999-4915

Record details

Read More Add to Saved list
×
Academic Journal

A molnupiravir-associated mutational signature in global SARS-CoV-2 genomes.

Subjects: Antiviral Agents*/Antiviral Agents*/Antiviral Agents*/pharmacology ; Antiviral Agents*/Antiviral Agents*/Antiviral Agents*/therapeutic use ; COVID-19*/COVID-19*/COVID-19*/epidemiology

  • Source: Nature [Nature] 2023 Nov; Vol. 623 (7987), pp. 594-600. Date of Electronic Publication: 2023 Sep 25.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 0410462 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Phylogeny and evolution of SARS-CoV-2 during Delta and Omicron variant waves in India.

  • Authors : Singh UB; Department of Microbiology, All India Institute of Medical Sciences, New Delhi, India.; Deb S

Subjects: SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/genetics ; Phylogeny* ; COVID-19*/COVID-19*/COVID-19*/virology

  • Source: Journal of biomolecular structure & dynamics [J Biomol Struct Dyn] 2024 Jun; Vol. 42 (9), pp. 4769-4781. Date of Electronic Publication: 2023 Jun 15.Publisher: Taylor & Francis Country of Publication: England NLM ID: 8404176 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

COVID-19 genome surveillance: A geographical landscape and mutational mapping of SARS-CoV-2 variants in central India over two years.

  • Authors : Khairnar K; Environmental Epidemiology & Pandemic Management (EE&PM), Council of Scientific and Industrial Research-National Environmental Engineering Research Institute (CSIR-NEERI), Nagpur, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, UP, India. Electronic address: .

Subjects: SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/genetics ; SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/classification ; SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/isolation & purification SARS-CoV-2 variants

  • Source: Virus research [Virus Res] 2024 Jun; Vol. 344, pp. 199365. Date of Electronic Publication: 2024 Mar 29.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8410979 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
  • 1-10 of  1,040 results for ""COVID-19""